MUNICH, Germany, June 20, 2023 (GLOBE NEWSWIRE) HMNC Brain Health (‘‘HMNC’’ or the ‘‘Company’’), a global clinical-stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced today
A new study from Harvard's School of Public Health suggests forgiving others has mental health benefits. University of Memphis psychology professor Dr. M. David Rudd weighed in.
Pharmaceutical Physician, Clinical Neuroscientist, and Psychiatrist with professional experience in the pharmaceutical industry accelerates Company efforts in clinical developmentMUNICH, Germany, May 08
German tech company HMNC Brain Health aims to use AI to predict, diagnose and treat depression. CMO Dr. Hans Eriksson and Dr. Daniel Gerlach, associate scientific director, weighed in.